NCT06300398View on ClinicalTrials.gov

IAMA-6 Oral Dose Study in Healthy Adults

PHASE1RecruitingINTERVENTIONAL
Enrollment

72

Participants

Timeline

Start Date

January 8, 2024

Primary Completion Date

September 30, 2024

Study Completion Date

September 30, 2024

Conditions
Neurodevelopmental Disorders
Interventions
DRUG

IAMA-6

IAMA-6 liquid suspension

DRUG

Placebo

Placebo-to-match IAMA-6 liquid suspension

Trial Locations (1)

Unknown

RECRUITING

Centro Ricerche Cliniche Di Verona S.r.l., Verona

Sponsors
All Listed Sponsors
lead

Iama Therapeutics S.r.l.

INDUSTRY